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Studies of protein-protein interactions deep in
organs and in whole mammals have been hindered
by a lack of genetically encoded fluorescent probes
in near-infrared region for which mammalian tissues
are the most transparent. We have used a near-
infrared fluorescent protein iRFP engineered from a
bacterial phytochrome as the template to develop
an in vivo split fluorescence complementation probe.
The domain architecture-based rational design re-
sulted in an iSplit reporter with the spectra optimal
for whole-body imaging, high photostability, and
high complementation contrast, which compares
favorably to that of other available split fluorescent
protein-based probes. Successful visualization of
interaction of two known protein partners in a living
mouse model suggests iSplit as the probe of choice
for noninvasive detection of protein-protein interac-
tions in vivo, whereas its fast intracellular degrada-
tion enables time-resolved monitoring of repetitive
binding events.
INTRODUCTION
Protein-protein interactions (PPIs) underlie many intracellular
processes. Initial investigations of PPIs utilized in vitro tech-
niques such as a coimmunoprecipitation and later advanced
to more elaborate approaches capable of PPI detection in live
cells. A bimolecular fluorescence complementation (BiFC) is
one of the later approaches and is based on the tagging of
two proteins with half of a fluorescent protein (FP) each. Upon
interaction of these proteins, the two halves of the FP (denoted
as split FP) associate with each other to form a fluorescent
complex, thus reporting on the PPI. The split protein approach
was first proposed and tested for ubiquitin reconstitution
(Johnsson and Varshavsky, 1994) and after proving the general
concept was applied to a number of enzymes and FPs. The
fluorescent split reporters have been engineered using ten
different FPs and their mutants (Table 1). Many of them have
been applied for studying various PPI events in live cells (Ker-
ppola, 2009); however, certain properties of the current split
FPs impose limitations to their use. Split FPs have a tendency1078 Chemistry & Biology 20, 1078–1086, August 22, 2013 ª2013 Elfor self-association, which decreases the BiFC contrast (Table
1). This has limited the highest reported contrast for cultured
cell expression to 17 for a Venus FP derivative (Kodama and
Hu, 2010). Another drawback of many split FPs is a poor matu-
ration at 37C, limiting their applicability to cells of nonmamma-
lian origin. The latter property worsens in split constructs
derived from red FPs, thus hindering multicolor BiFC for the
detection of several PPIs simultaneously. Recently, some prog-
ress has been made in the engineering of a split mLumin protein
(Chu et al., 2009); however, its further validation in mammalian
cells is necessary.
Studying PPIs with BiFC in living mammals puts stringent
requirements on the properties of the split FP reporter. In addi-
tion to good maturation at 37C, the reporter should possess
both excitation and emission maxima inside of a so-called
‘‘near-infrared optical window’’ (NIRW: 650–900 nm) where
mammalian tissues are relatively transparent because of low
absorption of hemoglobin, melanin, and water in this region.
Otherwise, good BiFC contrast observed in vitro will be unac-
ceptably low in vivo due to high tissue autofluorescence
caused by endogenous compounds, such as NADPH, flavins,
collagen, and elastin. To date, no far-red FPs have been engi-
neered into a BiFC reporter suitable for in vivo imaging. Split
mLumin might provide some advance in this direction,
although its spectral properties are suboptimal for applications
in mammals. Notably, whole-body split reporter-based imag-
ing was successfully facilitated using luciferase (Luker et al.,
2004, 2012; Paulmurugan et al., 2002) and thymidine kinase
(Massoud et al., 2010), resulting in chemiluminescence and
positron emission signals, respectively. However, both types
of reporters require injection of exogenous substrates and, in
the latter case, provide low contrast and nonspecific signal
in vivo.
The high demand for functional in vivo BiFC reporters
prompted a search for novel types of protein templates.
Recently, two near-infrared fluorescent proteins with both exci-
tation and emission spectra in NIRW engineered from bacterial
phytochromes have been reported and expressed in mammals
(Filonov et al., 2011; Shu et al., 2009). One of them, iRFP protein
(Filonov et al., 2011), appeared to be a good candidate for
designing an in vivo PPI probe because it possesses high in vivo
brightness and low cytotoxicity and utilizes endogenous con-
centrations of biliverdin (BV) chromophore to acquire fluores-
cence. Here, we describe the development, characterization in
mammalian cells, and validation of in vivo applicability of a
near-infrared split reporter based on iRFP protein.sevier Ltd All rights reserved
Table 1. Comparison of Major Properties for Available BiFC Reporters Based on Fluorescent Proteins
Parental FP Used
for Engineering
BiFC Reporter
Ex/Em Maxima of Parental
FP Identity of Ex/Em
Maxima with That of BiFC
Reporter) (nm) Interacting Pair Used
BiFC Contrast in
Cultured Mammalian
Cells (Fold)
Temperature Sensitivity
of Maturation of BiFC
Reporter Reference
ECFP 452/478 (yes) ZIP domains of Fos
and Jun
10 at 30C yes (poor maturation
at 37C)
Hu and Kerppola,
2003
EGFP-sg25 475/505 (yes) Leucine zippers ND ND Ghosh et al., 2000
EGFP 488/507 (no, 490/524) biotinilated DNA
oligonucleotides
ND ND (experiments
were at RT)
Demidov et al., 2006
mKG 494/506 (ND) leucine zippers, PX
with PB1 of p40phox
ND no Ueyama et al., 2008
TCF7 with b-catenin,
PAC1 with PAC2, PAC3
homodimerization
Hashimoto et al.,
2009
Dronpa 503/518 (activated form)
(ND)
hHus1 with hRad1 ND no Lee et al., 2010
EYFP 514/527 (yes) ATF2 with Jun, p50
with Fos, p65 with Jun
10 at 30C Yes (poor maturation
at 37C)
Hu et al., 2002
ZIP domains of Fos
and Jun
Hu and Kerppola,
2003
Venus 515/528 (ND) ZIP domains of Fos
and Jun
10 at 37C no Shyu et al., 2006
Venus (V150A) 10 at 37C Nakagawa et al.,
2011
Venus (I152L) 17 at 37C Kodama and Hu,
2010
mRFP1-Q66T 549/570 (ND) CPC with GL3, BP/
KNAT1 with BLH7
15–20 (in plant
cells only)
ND (experiments were
at 26C –28C.)
Jach et al., 2006
mCherry 587/610 (ND) SV40 large T antigen
with p53
ND yes (poor maturation
at 37C)
Fan et al., 2008
mLumin 587/621 (ND) ZIP domains of Fos and
Jun, EGFR with Grb2,
STAT5A with STAT5B
ND no Chu et al., 2009
iRFP 690/713 (yes) E-coil with K-coil,
FRB with FKBP
50–80 at 37C no This paper
ND, not determined; RT, room temperature.
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iRFP Protein as a Template for the Split Reporter
iRFP has retained two distinct domains PAS and GAF from
its parental bacterial phytochrome RpBphP2 (PHY and HisK
domains were excluded from the protein on the first stage of
the iRFP engineering). This suggested that the products of sepa-
rating iRFP between the two domains might demonstrate split
FP properties. Having aligned the sequence of iRFP with that
of RpBphP3 (a close homolog of the iRFP’s parental RpBphP2
with a known crystal structure), we proposed that the optimal po-
sition for the introduction of polypeptide breakwould be in an un-
structured loop spanning between amino acid residues 120–123
(numbering as in iRFP) between the PAS and GAF domains (Fig-
ure S1 available online). To test this in bacteria, independent pro-
duction of these two domains was facilitated by a plasmid
bearing two different promoters (rhamnose and arabinose
dependent) (Figure S2A). To induce complex formation of the
separated PAS and GAF domains, they were fused to coils
(namedE-coil and K-coil) previously reported to be capable of in-Chemistry & Biology 20, 1078–teracting with each other with a high affinity (Kd = 63 pM) (De
Crescenzo et al., 2003) (Figure S2B). Cotransformation of the
dual-promoter plasmid encoding the PAS-E and K-GAF fusion
constructs with a plasmid encoding heme oxygenase allowed
simultaneous expression of the fusions and production of BV.
BV is an exogenous chromophore for iRFP that is necessary
for the formation of the fluorescent adduct. Upon induction of
transcription of the split fusions, the producing bacterial cells
demonstrated a clear fluorescent signal. The fluorescent signal
was 10-fold lower than that of bacteria expressing full-length
iRFP yet40-fold higher than the signal from the cells producing
the PAS and GAF domains not fused to coils (Figure S3A),
providing the BiFC contrast of 40-fold. BiFC contrast is a con-
ventional notion in the field of split reporters that describes the
difference between the real, induced signal, and background
fluorescence, originated from a nonspecific split reporter
complementation. Thus, the separated PAS and GAF domains
of the iRFP protein retained their ability to reacquire fluorescent
properties upon induced close proximity and had a low nonspe-
cific interaction.1086, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1079
Figure 1. Properties of the iSplit Complex In Vitro and in Cultured Cells
(A) iSplit fluorescence brightness and complementation contrast in cultured cells are shown. HeLa cells were transfected with plasmids encoding the proteins
indicated, and the brightness was analyzed using flow cytometry. Rapamycin (100 nM) was added to the culture media 24 hr before the analysis where indicated.
(B) Fluorescence images of the transfected HeLa cells without iSplit formation (top) and after the iSplit complementation (bottom). Scale bar is 20 mm.
(C) Absorbance spectrum of the purified iSplit complex with a peak value at 280 nm set to 100%.
(D) Fluorescence excitation and emission spectra of the purified iSplit complex, normalized to 100%.
(E) Photobleaching of iSplit expressed in HeLa cells measured using Olympus IX81 inverted microscope equipped with a 200 W arc lamp, a 603 1.35 NA oil
immersion objective lens, and a 665/45 nm filter.
(F) Assessing the dissociation constant for the FRB-rapamycin-FKBP complex where FRB or FKBP partners are fused to the iSplit fragments. Different con-
centration of rapamycin were added to the transfected HeLa cells and incubated for 22 hr followed by FACS analysis. The dashed line is a sigmoidal fitting based
on Hill equation (R2 = 0.99656).
See also Figures S1, S2, and S3.
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To increase the brightness of the split iRFP complex in bacteria,
we next subjected one of the domains to random mutagenesis.
The GAF domain is larger and contains a BV chromophore bind-
ing pocket, so we chose to mutate it first. One round of random
mutagenesis substantially increased the fluorescent brightness
of bacteria producing the split iRFP complexes (Figure S3B).
Because the fluorescence brightness of bacteriophytochrome-
based FPs in mammalian cells depends on their affinity to
endogenous BV (Filonov et al., 2011), we further tested the
obtained mutants of the GAF domain in HeLa cells. To accom-
plish this, the PAS-E and K-GAF (mutant) genes were cloned
into two plasmids under the same promoter. Fluorescence-acti-
vated cell sorting (FACS) used to compare the mutants in
mammalian cells showed that the reconstitution of the split
iRFP complexes resulted in bright cell fluorescence at an endog-
enous BV concentration below 1 mM (Filonov et al., 2011) (Fig-
ure S3C). Although further rounds of random mutagenesis of
either the PAS or GAF domains slightly increased brightness
of the split complexes, it decreased the iRFP complementation
contrast. Thus, we decided to continue with the complex
obtained after the first mutagenesis round. This complex, named1080 Chemistry & Biology 20, 1078–1086, August 22, 2013 ª2013 EliSplit, consists of the original PAS domain and GAF domain with
three substitutions, which we denoted GAFm (Figure S1).
Characterization of the Split Reporter in Cells
FACS analysis of the transiently transfected HeLa cells demon-
strated that iSplit has a contrast of 50-fold compared to the
control PAS/K-GAFm pair (Figure 1A). We then chose another
protein pair to drive a stimulus-dependent iSplit formation and
fused PAS and GAFm to an N terminus of a FRB protein and
a C terminus of a FKBP protein, respectively (Figure S2C). The
FRB and FKBP partners interact upon addition of rapamycin
(Luker et al., 2004). The induced interaction between the PAS-
FRB and FKBP-GAFm fusion constructs yielded an 35-fold
increase in the HeLa cell brightness. The PAS and GAFm
domains expressed separately or as the PAS/GAFm combination
without induction had a very low fluorescent level close to back-
ground (Figure 1A). These results were supported bymicroscopy
imaging of transfected HeLa cells (Figure 1B). An observed
nuclear localization of the PAS-FRB/FKBP-GAFm complex was
caused by a nuclear localization signal at the N terminus of the
FKBP partner. Exclusion of the PAS-E/K-GAFm pair from nuclei
was possibly caused by the large molecular weight of the iSplitsevier Ltd All rights reserved
Figure 2. Behavior of the iSplit Complex in
Mammalian Cells
(A) Irreversibility of iSplit complex. HeLa cells were
transfected with plasmids encoding either the
PAS-FRB or FKBP-GAFm fusion and incubated
with 100 nM of rapamycin for 24 hr. Cells in column
A were left untreated as a control. Then, these
cells (except column B) were washed with PBS,
medium was changed, and FK506 (specific
competitor of rapamycin) was added to final con-
centrations of 10 mM (column C), 20 mM (column
D), 50 mM (column E), and 100 mM (column F). After
incubation for additional 24 hr, all cells were har-
vested and analyzed with FACS.
(B) Kinetics of the fluorescence increase in MTLn3
preclonal stable cells after addition of 100 nM
rapamycin.
(C) Intracellular stability of iSplit in MTLn3 pre-
clonal stable cells in comparison with iRFP. Cells
were preincubated with 100 nM rapamycin for
24 hr and then washed (or left with rapamycin) and
treated or not with 30 mg/ml cycloheximide (CHX).
(D) Fluorescence brightness of MTLn3 preclonal
stable cells expressing iSplit after 100 nM rapa-
mycin addition and washout cycles analyzed by
FACS at the indicated time points.
In all panels, error bars represent the 95% confi-
dence intervals calculated based on either three
samples in FACS analysis or several cells from
three fields of view inmicroscopy. See also Figures
S4 and S5.
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nuclear pore (Marfori et al., 2011). Overall, the iSplit complexes
did not form aggregates or localize to any specific compartment
(Figure 1B).
These results prompted us to study the iSplit spectroscopic
properties in more detail. Split iRFP eluted from bacteria
has the same absorbance, excitation, and emission peaks as
parental iRFP (Figures 1C and 1D). The extinction coefficient,
measured by comparison to the absorbance of free BV as previ-
ously described (Filonov et al., 2011), provided a value of
85,500 ± 830 M1cm1, which was slightly lower than an extinc-
tion coefficient of 105,000M1cm1 for parental iRFP. The quan-
tum yield of iSplit was 6.2% ± 0.5%, which is close to 5.9% of
iRFP. The iSplit photostability in live mammalian cells was similar
to that of iRFP with the half-time being 33.0 ± 5.2 min (Figure 1E),
whereas for iRFP the half-time measured using the same condi-
tions was 26 min (Filonov et al., 2011).
Next, we studied whether the PAS or GAFm domains sepa-
rately or combined could affect the binding efficiency of the
FRB/FKBP partners. Transfected HeLa cells expressing the
PAS-FRB/FKBP-GAFm complex were incubated with different
concentrations of rapamycin and then FACS analyzed to plot a
titration curve (Figure 1F). The rapamycin-induced fluorescence
intensity of these cells, fitted with a curve based on the Hill equa-
tion, showed saturable binding with the EC50 being 11.6 ±
0.7 nM, close to the Kd value determined in vitro (12 nM) (Banas-
zynski et al., 2005). This indicated that the PAS andGAF domains
did not affect the binding properties of FRB and FKBP.
In order to evaluate the irreversibility of the iSplit complex for-
mation, HeLa cells expressing the PAS-FRB and FKBP-GAFm
fusions and preincubated with rapamycin were washed andChemistry & Biology 20, 1078–then treated with FK506, which is a competitive inhibitor of the
FRB and FKBP interaction. Suitably, even high concentrations
of FK506 did not cause a decrease in the fluorescence intensity,
thus indicating the irreversible nature of the iSplit formation. BiFC
irreversibility is common for other FP-based split partners as well
(Shyu and Hu, 2008) (Figure 2A).
Because the main application of iSplit was conceived for
in vivo imaging (see below), we made a stable preclonal mixture
of the MTLn3 breast adenocarcinoma cells coexpressing
E2-Crimson far-red FP (excitation 605 nm, emission 646 nm)
(Strack et al., 2009) as a volumetric marker, and the PAS-FRB
and FKBP-GAFm fusions. The stably expressing PAS-FRB/
FKBP-GAFm cells provided a BiFC contrast of up to 80-fold
upon rapamycin addition and brightness of 25% of the MTLn3
cells stably expressing iRFP (Filonov et al., 2012) (Figure S4).
We then measured the kinetics of cellular fluorescence upon
addition of rapamycin using microscopy (Figure 2B). A BiFC
contrast of 10-fold was reached as early as 4.5 hr after addition
of rapamycin.
To study the intracellular stability of iSplit, the MTLn3 stable
cells preincubated with rapamycin were washed and then either
left in the medium only or in the medium with 30 mg/ml cyclohex-
imide. The iSplit complex degraded rapidly with a half-time of
3.8 hr (Figure 2C). Addition of rapamycin to the cells with cyclo-
heximide resulted in a similar fluorescence decay, indicating that
intracellular complex degradation and not complex dissociation
caused the fluorescence decrease. Without cycloheximide,
the iSplit half-time increased to 21.6 hr, possibly due to resid-
ual rapamycin left in the cells. The control iRFP-expressing
cells demonstrated the expected high protein stability (Filonov
et al., 2011).1086, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1081
Figure 3. Expression of the iSplit Complex in Living Mice
(A) Representative images of a mouse bearing a 3-week-old MTLn3 tumor coexpressing E2-Crimson and PAS-FRB and FKBP-GAFm pair before (left image) and
36 hr after (middle image) the rapamycin intraperitonial injection (4.5 mg/kg) imaged in a 675/30–720/20 nm excitation-emission near-infrared channel for iSplit
imaging (top) and in a 605/30–660/20 nm excitation-emission far-red channel for tumor volume assessment by means of E2-Crimson fluorescence (bottom). A
mouse on the right is the autofluorescence control. Scale bar is 1 cm.
(B) Quantification of the near-infrared fluorescence intensities of the mice in (A). Fluorescence brightness before rapamycin injection (black bar), 36 hr after the
injection (red bar), and that of the control mouse (green bar) is shown. Subtraction of the autofluorescence background from the fluorescence signals before and
after the rapamycin injection results in 23-fold difference. Error bars represent the 95% confidence interval calculated based on three subsequent images.
(C) Kinetics of the near-infrared fluorescence change in mice with MTLn3 tumors injected with either rapamycin (red diamonds) or vehicle (black squares). The
near-infrared fluorescence intensity for each mouse was normalized to the E2-Crimson far-red signal, and the resulting value was normalized to a value at time
0 hr to plot the fluorescence changes. Error bars represent the SD values of the fluorescent intensity from threemice. Dashed line represents the b-spline fitting of
the ratio of fluorescence from the mice injected with rapamycin and with vehicle. The latter normalization takes into the account spontaneously associated iSplit.
(D) Postmortem near-infrared images of theMTLn3 tumors cut in halves shortly after the isolation frommice. The tumorswith noncomplemented iSplit (left image),
complemented (middle image) iSplit, and expressing iRFP are shown. Scale bar is 1 cm.
(E) FACS analysis of the MTLn3 cells isolated from the tumors in (D).
See also Figures S6 and S7.
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over of the iSplit complex could provide the possibility of study-
ing PPIs several times in the same cells, especially because the
timescale of in vivo experiments is typically days. To validate this
hypothesis, we used the same MTLn3 cells to turn the iSplit
complex formation on and off several times (Figure 2D). The cells
were rapamycin pretreated, FACS analyzed, washed out, FACS
analyzed after additional time, and rapamycin pretreated again
to complete the iSplit complex formation-degradation cycle.
Indeed, the fluorescence intensity of the cells showed the antic-
ipated cyclic behavior with some fluorescence increase as the
cycles progressed, likely due to intracellular accumulation of
rapamycin.
To test whether the iSplit formation is affected by exogenous
BV, we added varying BV amounts to either MTLn3 cells coex-
pressing PAS-FRB/FKBP-GAFm pretreated with rapamycin or
MTLn3 cells expressing iRFP, which possesses a high affinity
to BV (Filonov et al., 2011). Both types of cells showed a low fluo-
rescence dependence on the BV level, indicating that iSplit has
an affinity to BV similar to that of iRFP and utilizes mostly endog-
enous BV to exhibit fluorescence (Figure S5).1082 Chemistry & Biology 20, 1078–1086, August 22, 2013 ª2013 ElPerformance of the Split Reporter in Live Animals
Having characterized the iSplit properties in vitro and in cultured
cells, we utilized MTLn3 cells stably coexpressing E2-Crimson,
PAS-FRB, and FKBP-GAFm to develop a tumor xenograft
in living mice (see Experimental Procedures for details). Mice
were first imaged 3 weeks after the cancer cell injection. Both
the bright signal from E2-Crimson and the faint signal from non-
induced iSplit were detected and spectrally resolved without
interference (Figures 3A and S6), thus demonstrating the
capability of iRFP and its derivatives to be used for two-color
in vivo imaging. Upon rapamycin injection, a strong near-
infrared fluorescence increase of up to 23-fold at 36 hr after
the injection was observed in all animals (Figure 3B), whereas
the vehicle injection did not cause fluorescence changes (Fig-
ures 3A and 3B).
Figure 3C shows kinetics of the rapamycin-induced fluores-
cence change normalized to the E2-Crimson fluorescence signal
that takes into account differences in the proteins expression
level and tumor size. The dashed line represents additional
normalization to the spontaneous iSplit association. The iSplit
signal reached an average of 18-fold contrast at 40 hr aftersevier Ltd All rights reserved
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Another injection of rapamycin into the same mice caused the
second wave of the fluorescence increase though with a lower
contrast of 7.5-fold due to the increased nonspecific signal
from the accumulated iSplit complex. The decrease of BiFC
contrast with time (Figure 3C) does not reflect the fluorescence
intensity of the tumors, which, in fact, increased during the
course of the experiment (Figure S7).
The postmortem fluorescence intensities of the several-week-
old iSplit-expressing tumor, which was rapamycin-induced and
excised at maximal brightness, and the iRFP-expressing tumor
of similar size differed 3.2-fold, with iRFP being the higher
intensity tumor. Both tumors demonstrated even fluorescence
distribution inside (Figure 3D). FACS analysis of cells isolated
from these tumors showed decreased fluorescence compared
to the original cultured cells (Figures 3E and S4). However, the
relative brightness between the iSplit- and iRFP-expressing
tumor cells (Figure 2E) remained similar to that obtained in
cell culture, suggesting the same low cytotoxicity for iSplit as
observed before for iRFP (Filonov et al., 2011).
DISCUSSION
The obtained results have demonstrated that two-domain
bacteriophytochrome-derived iRFP is a good candidate for engi-
neering split probes and does not require a laborious search for a
position for the polypeptide break as in the case of GFP-like pro-
teins. It is likely that other bacteriophytochrome-based FPs, all
having multidomain structures, could be converted into BiFC
reporters using similar positions.
iSplit has retained the majority of its parental near-infrared
spectral and biochemical properties. With the BiFC contrast of
50- to 80-fold in cultured mammalian cells, iSplit compares
favorably to available split reporters based on GFP-like FPs,
which may also exhibit poor maturation at 37C (Table 1), lucifer-
ases, and thymidine kinase with maximum intracellular contrasts
of 17-fold (Kodama and Hu, 2010), 20- to 75-fold (Villalobos
et al., 2010), and 3-fold (Massoud et al., 2010), respectively.
iSplit is the BiFC reporter that has been imaged in a whole
animal, moreover, with 18-fold contrast. Compared to luciferase
and thymidine kinase, iSplit does not require injection of exoge-
nous substrates. Moreover, fast degradation of iSplit could be
beneficial for the visualization of the relatively slow dynamics
of PPI in the body, because the fluorescent signal will fade
soon after the specific stimulus is gone.
Similar to other PPI systems used in live cells, the iSplit re-
porter is not precisely quantitative because its fluorescent signal
is determined by a number of factors, including PAS and GAFm
domains association, folding and BV-binding kinetics, rates of
these proteins’ synthesis, and degradation. However, this is
the only currently available in vivo PPI reporter system that
does not depend on exogenous substrates. Ideally, the iSplit re-
porter should be used to assess or prove in vivo interaction of
proteins, whereas precisemeasurements of the protein-partners
binding properties should be done in vitro with more appropriate
techniques.
The difference in the iRFP and iSplit intracellular stabilities can
be a result of distinct folding pathways for these proteins. iRFP
folds while translated as a single polypeptide chain and thisChemistry & Biology 20, 1078–way adopts its intrinsic structure. iSplit is synthesized as two
different protein moieties, which likely prefold separately and
reach their final conformation once brought into proximity. It is
likely that the resulting folds of these proteins have differences,
and iSplit possesses some structural elements, which confer
its cellular instability. One of these apparent structural differ-
ences may be a trefoil knot (Wagner et al., 2005).
To overcome possible negative effects of the irreversibility of
the current iSplit variant, a split protein reconstitution based on
an intein-mediated protein splicing can be utilized (Paulmurugan
et al., 2002). This approach involves incorporation of the intein
split fragments into the protein-FP fusion. Once proteins in study
interact, the intein halves are brought together and perform pro-
tein splicing, which results in ligation of two halves of FP and
dissociation of the resulting full-length protein. Because iSplit
is an unstable protein, its fluorescent signal should rapidly fade
away, whereas the protein partners will now be set free for
further biochemical events. This sketch reporter system could
be more physiological than the iSplit reporter.
Alternatively, in case of the fast cellular events irreversibly
building up, iSplit could allow imaging of transient and low abun-
dant interactions. Also, other more sophisticated complementa-
tion strategies suggested for luciferase-based split reporter can
also be applied to the iSplit system, thus further expanding its
application range (Shekhawat et al., 2009).
Last, the dimeric nature of iRFP, likely inherited by its iSplit
derivative, may hinder novel PPI screening but should not be
an obstacle in transferring protein complex studies from cell cul-
ture to animal models. Other in vivo applications of iSplit could
include studies of PPIs in processes at cellular and tissue bor-
ders including wound healing, host-pathogen interactions, and
organ development. One of the promising applications of iSplit
can be its use to extend the GRASP technology and image
cell-cell contacts in live mammals (Feinberg et al., 2008).
SIGNIFICANCE
Our work presents the model example of molecular engi-
neering of a bacteriophytochrome based BiFC reporter to
study protein-protein interactions. The high contrast of the
specific to nonspecific fluorescent signals in the combina-
tion with the near-infrared excitation and emission spectra
of the iSplit reporter allows detecting interactions in vivo,
which has been successfully demonstrated in the mice
tumor model.
EXPERIMENTAL PROCEDURES
Plasmid Construction
To generate arabinose and rhamnose inducible plasmids for bacterial
expression, the following cloning was done. A pWA21cBP-EGFP-mTagBFP
plasmid (see below) was digested with PstI and BglII, and PCR products
encoding either a PAS domain of iRFP or the PAS domain fused to an E-coil
sequence with the same enzymes were ligated resulting in the pWA-PAS
and pWA-PAS-E plasmids, respectively. The plasmids were further digested
with NotI and XmaJI. A fragment encoding AraC protein, an arabinose-induc-
ible promoter and a multicloning site linker, was PCR amplified from a pBAD-
HisB plasmid (Invitrogen) and digested with the same enzymes. The digested
pWA-PAS and pWA-PAS-E plasmids and the PCR fragment were ligated
resulting in the pWA-PAS-BAD and pWA-PAS-E-BAD plasmids, respectively.
Last, the GAF domain of iRFP and a K-GAF fragment were PCR amplified and1086, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1083
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BAD-GAF and pWA-PAS-E-BAD-K-GAF plasmids, respectively. The E-coil
and K-coil sequences were synthesized de novo based on the amino acid
sequence (De Crescenzo et al., 2003), and a -ggs- linker was inserted between
the coil fragments and the PAS and GAF domains.
A pWA21cBP-EGFP-mTagBFP plasmid was constructed as follows. The
gene coding the AraC DNA-binding domain was inserted into the pWA21
plasmid (Wegerer et al., 2008) at BsrGI/HindIII restriction sites after PCR ampli-
fication from the pBAD/HisB plasmid (Invitrogen). A pWA21c-AvrIINotI plasmid
was next generated by site-specific mutagenesis of the pWA21c plasmid to
insert AvrII and NotI sites. The pWA21c-AvrIINotI plasmid was converted
into a pWA21cBAD plasmid by cloning the PCR-amplified DNA AvrII/NotI
fragment encoding a pBAD promoter into the pWA21C-AvrIINotI plasmid.
The pWA21cBAD was then converted into pWA21cBP using site-specific
mutagenesis to insert PstI site. Last, the pWA21cBP plasmid was engineered
into the pWA21cBP-EGFP-mTagBFP plasmid via inserting of the mTagBFP
gene (Subach et al., 2008) at NcoI/KpnI sites. The EGFP gene was present
in the original pWA21 plasmid.
A pWA23h plasmid was engineered to provide expression of a heme
oxygenase for biliverdin production in bacteria. It contained the rhamnose
promoter from the pWA21 plasmid (Wegerer et al., 2008), Kan resistance,
and COLA origin parts from a pCOLADuet-1 plasmid (Novagen). First, the
AvrII/PciI fragment containing Kan resistance and COLA origin was PCR
amplified from pCOLADuet-1 plasmid and inserted into a pWA21h-AvrIINotI
vector. Then, a hmuO gene encoding Bradyrhizobium ORS278 heme oxy-
genase was PCR amplified from pBAD(hisB)-RpBPhP2-hmuO plasmid
(Giraud et al., 2005) and swapped with the EGFP gene in the pWA21-AvrIINotI
plasmid.
Mammalian expression of the PAS-E and K-GAF domains for the constitu-
tive complex formation was driven from the plasmids pPAS-E and pK-GAF
generated as follows. A pEGFP-C1 plasmid (Clontech) was digested
with NheI and BglII and ligated with PCR fragments encoding either the
PAS or GAF domains of iRFP fused to the respective coils and digested
with the same enzymes. A control pPAS plasmid containing no coil was gener-
ated after ligation of the piRFP plasmid (Filonov et al., 2011) digested with
NheI and BamHI, and the PCR amplified PAS domain was digested with
NheI and BglII.
To generate eight plasmids for the rapamycin dependent interaction of the
PAS andGAF containing various fusions, the pC4-RHE or pC4EN-F1 plasmids
(ARIAD Pharmaceuticals) encoding FRB or FKBP partners, respectively, were
digested with either XbaI or SpeI and ligated with the PCR amplified PAS or
GAF domains digested with the same enzymes. The -ggggsggggs- linkers
were used between the PAS or GAF domains and the respective partner.
The resulting plasmids pC4-RHE-PAS encoding PAS-FRB and pC4EN-F1-
GAFm encoding FKBP-GAFm were further used.
A pBABE-puro-E2-Crimson plasmid was engineered by inserting
E2-Crimson (Strack et al., 2009) DNA digested with EcoRI and SalI into the
pBABE-puro plasmid (Morgenstern and Land, 1990) digested with the same
enzymes.
Mutagenesis and Screening of Libraries
Randommutagenesis was performed with a GeneMorph II RandomMutagen-
esis Kit (Stratagene), using conditions that resulted in the mutation frequency
of up to 16 mutations per 1,000 base pairs. After the mutagenesis, a mixture of
mutants was electroporated into the LMG194 host cells (Invitrogen) containing
the pWA23h plasmid. Typical mutant libraries for FACS screening consisted of
106–108 independent clones. Following the transformation, the LMG194
bacteria were grown for 3 hr in SOC-rich medium and then centrifuged and
resuspended in RM medium with 0.002% arabinose, 0.2% rhamnose,
100 mM 5-aminolevulinic acid, and 50 mM FeCl3. The cells were then grown
up to 24 hr at 37C.
For FACS screening, bacteria were washed with phosphate buffered saline
(PBS) and then diluted with PBS to an optical density of 0.02 at 600 nm. A
MoFlo XDP cell sorter (Beckman Coulter) equipped with standard Ar, Kr,
and Ar-Kr mixed-gas lasers was used. Typically, about ten sizes of each library
were FACS sorted, using a 676 nm Kr laser line for excitation and a 700LP nm
emission filter for positive selection. The brightest collected infrared bacterial
cells were rescued in a SOC medium at 37C for 1 hr and then plated on Petri1084 Chemistry & Biology 20, 1078–1086, August 22, 2013 ª2013 Eldishesmade of RM/agar supplemented with ampicillin, kanamycin, arabinose,
and rhamnose. After overnight expression at 37C, colonies were analyzed
using a Leica MZ16F fluorescence stereomicroscope equipped with the
650/45 nm excitation and 690LP nm emission filters (Chroma). The 20–30
brightest clones were selected, and their DNA was sequenced.
Characterization of Split iRFP Complex In Vitro
The PAS-E/K-GAF complex was produced in the LMG194 bacterial cells as
described above and then purified with a Ni-NTA agarose (QIAGEN) using a
6xHis tag attached to the N terminus of the PAS domain. Excitation and emis-
sion spectra were measured using a FluoroMax-3 spectrofluorometer (Jobin
Yvon). For absorbance measurements, a Hitachi U-2000 spectrophotometer
was used. An extinction coefficient was calculated based on a comparison
of absorbance values at the main peak at 692 nm with the absorbance value
at the 392 nm peak, assuming the latter had extinction coefficient of free BV
of 39,900 M1cm1. To determine a quantum yield, fluorescence signal of
the purified iSplit complex was compared to that of an equally absorbing
Nile Blue dye.
Cell Culture
HeLa cells were grown in Dulbecco’s Modified Eagle Media (DMEM, HyClone)
containing 10% fetal bovine serum (FBS), penicillin-streptomycin, and 2 mM
glutamine (Life Technologies). Rat adenocarcinoma MTLn3 cells were grown
in alpha MEM (Gibco) containing 5% FBS and penicillin-streptomycin. Prior
imaging cells were cultured in 35 mm glass-bottom culture dishes with no. 1
cover glasses (MatTek Corporation).
Plasmid transfections were performed using an Effectene reagent (QIAGEN)
according to the manufacturer’s protocol.
To create stable preclonal mixture of the MTLn3 cells expressing E2-
Crimson, the pBABE-puro-E2-Crimson plasmid was used to generate retrovi-
ruses, as described (Piatkevich et al., 2010). Upon infection, the MTLn3 cells
were maintained with 1.0 mg/ml puromycin (Life Technologies).
Stably expressing cells based on MTLn3 with E2-Crimson were selected
with 700 mg/ml G418 following by cotransfection with the pC4-RHE-PAS,
pC4EN-F1-GAFm, and pcDNA3.1 (Invitrogen) (to confer G418 resistance) plas-
mids. Sorting of positive cells was performed with the MoFlo XDP cell sorter.
The collected cells were maintained on both puromycin and G418.
Characterization in Mammalian Cells
To study brightness in mammalian cells, the respective pairs of plasmids were
cotransfected. In case of one relevant plasmid needed, the pEGFP-C1 plasmid
(Clontech) was used as a mock. In all cases, the pmTagBFP2-C1 plasmid
(Subach et al., 2011) was added in a ratio of 1:5 to total plasmid amount
to normalize for transfection efficiency. Rapamycin (LC Laboratories) was
typically added 24 hr before analysis to the final concentration of 100 nM. Fluo-
rescence intensity of cells was analyzed using a LSRII cytometer (BD Biosci-
ences) equipped with 404, 561, and 640 nm lasers and utilizing 405/50, 610/
20, and 730/45 nm filters. To quantify cell fluorescence, a mean fluorescent
intensity of the nonnegative population in the near infrared channel was
divided by a mean fluorescent intensity of the same population in the blue
channel, thus normalizing the near-infrared signal to the transfection effi-
ciency. The analysis also included a compensation of the leakage of the E2-
Crimson fluorescence into the near infrared channel. All FACS calculations
were performed using FlowJo software (Tree Star).
To assess the FRB/FKBP binding constant, different amounts of rapamycin
were added to HeLa cells 40 hr after the transfection and FACS analyzed
22 hr later.
Imaging of HeLa cells was performed 48 hr after the transfection. The HeLa
and MTLn3 stably expressing cells were imaged using an Olympus IX81
inverted epifluorescence microscope equipped with LumenPro200 200 W
metal-halide arc lamp (Prior), a 603 1.35 numerical aperture (NA) oil immersion
objective lens (UPlanSApo, Olympus), and a standard Cy5.5 filter set (665/
45 nm exciter and 725/50 nm emitter) (Chroma). To study fluorescence growth
in MTLn3 preclonal mixture coexpressing PAS-FRB/FKBP-GAFm complex
upon 100 nM rapamycin treatment, an environmental chamber with the tem-
perature control (Precision Control) was used to keep the temperature at 37C.
Photobleaching measurements of the nuclear localized PAS-FRB/FKBP-
GAFm complex (iSplit) in the stable preclonal mixture of MTLn3 cells weresevier Ltd All rights reserved
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scope, as described (Filonov et al., 2011).
For the protein degradation assay, the stable preclonal mixture of MTLn3
cells expressing PAS-FRB/FKBP-GAFm complex and incubated with 100 nM
rapamycin for 24 hr or stable preclonal mixture of MTLn3 cells expressing
iRFP (Filonov et al., 2012) were washed with PBS and then treated with
30 mg/ml of cycloheximide (with addition of 100 nM of rapamycin, where indi-
cated). Cellular brightness was assessed with FACS analysis, as described
above.
To study complementation-degradation cycling, the stable preclonal
mixture of MTLn3 cells expressing the PAS-FRB/FKBP-GAFm complex were
incubated with 100 nM rapamycin for 21 hr, washed with PBS, split in two
parts, and either passed to another dish or FACS analyzed. Nonanalyzed cells
were split in two 53 hr after that and either FACS analyzed or treated with
100 nM of rapamycin for an additional 21 hr to start the next cycle.
To check fluorescence dependence on BV concentration, the respective
amounts of exogenous BV were added to the stable preclonal mixture of
MTLn3 cells expressing PAS-FRB/FKBP-GAFm complex, preincubated with
100 nM rapamycin for 24 hr, or to the stable preclonal mixture of MTLn3 cells
expressing iRFP (Filonov et al., 2012).
In Vivo Fluorescence Imaging
One million MTLn3 cells stably expressing E2-Crimson with the PAS-FRB/
FKBP-GAFm complex, E2-Crimson alone, or iRFP alone were injected into
the mammary gland of SCID/NCr mice (female, 5–7 weeks old) (Taconic)
and imaged starting 3 weeks later using an IVIS Spectrum instrument
(PerkinElmer/Caliper) in epifluorescence mode. Rapamycin was dissolved in
100% ethanol to the concentration of 9 mg/ml and stored at 80C. Before
its intraperitoneal injection, the concentrated stock of rapamycin was diluted
in an aqueous solution of 5.2% Tween 80 and 5.2% PEG400. The typical
injected volume was 200 ml and resulted in 4.5 mg/kg concentration. The
IVIS Spectrum instrument was equippedwith 675/30 and 720/20 nm excitation
and emission filters for iSplit and iRFP imaging, and 605/30 and 660/20 nm
excitation and emission filters for E2-Crimson imaging. Belly fur was removed
using a depilatory cream. Mice were fed with AIN-93M Maintenance Purified
Diet (TestDiet) to reduce intrinsic autofluorescence level.
The iSplit- and iRFP-expressing MTLn3 tumors were excised postmortem,
cut in half, and imaged using the above setup of the IVIS Spectrum instrument.
Quantitative measurements of fluorescence signal were made with a Living
Image Software 4.0 (PerkinElmer/Caliper). Then, tumors were chopped into
pieces, washed with PBS supplemented with 2% of bovine serum albumin,
and subsequently filtered through sieves and a 35 mm filter. FACS analysis
was performed with the LSRII cytometer using 610/20 and 730/45 nm emis-
sion filters.
All animal experiments were performed in an AAALAC approved facility
using protocols approved by the Albert Einstein College of Medicine Animal
Usage Committee.
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